Global Market Direct’s pharmaceuticals report, “JADO Technologies GmbH - Product Pipeline Review - 2013” provides data on the JADO Technologies GmbH’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, JADO Technologies GmbH’s corporate website, SEC filings, investor presentations and featured press releases, both from JADO Technologies GmbH and industry-specific third party sources, put together by Global Markets Direct’s team.
- JADO Technologies GmbH - Brief JADO Technologies GmbH overview including business description, key information and facts, and its locations and subsidiaries. - Review of current pipeline of JADO Technologies GmbH human therapeutic division. - Overview of pipeline therapeutics across various therapy areas. - Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe. - Product profiles for late stage and clinical stage products of JADO Technologies GmbH with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones. - Recent updates of the JADO Technologies GmbH’s pipeline in the last quarter. - Key discontinued and dormant projects. - Latest news and deals relating to the products.
Reasons to buy
- Evaluate JADO Technologies GmbH’s strategic position with total access to detailed information on its product pipeline. - Assess the growth potential of JADO Technologies GmbH in its therapy areas of focus. - Identify new drug targets and therapeutic classes in the JADO Technologies GmbH’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas. - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps. - Exploit collaboration and partnership opportunities with JADO Technologies GmbH. - Avoid Intellectual Property Rights related issues. - Explore the dormant and discontinued projects of JADO Technologies GmbH and identify potential opportunities in those areas.
Table Of Contents
JADO Technologies GmbH - Product Pipeline Review - 2013 Table of Contents 2 List of Tables 3 List of Figures 3 JADO Technologies GmbH Snapshot 4 JADO Technologies GmbH Overview 4 Key Information 4 Key Facts 4 JADO Technologies GmbH - Research and Development Overview 5 Key Therapeutic Areas 5 JADO Technologies GmbH - Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products - Monotherapy 8 Partnered Products/Combination Treatment Modalities 9 JADO Technologies GmbH - Pipeline Products Glance 10 JADO Technologies GmbH Clinical Stage Pipeline Products 10 Phase II Products/Combination Treatment Modalities 10 JADO Technologies GmbH - Early Stage Pipeline Products 11 Pre-Clinical Products/Combination Treatment Modalities 11 JADO Technologies GmbH - Drug Profiles 12 J-555Y 12 Product Description 12 Mechanism of Action 12 RandD Progress 12 J-607Y 13 Product Description 13 Mechanism of Action 13 RandD Progress 13 J-775Y 14 Product Description 14 Mechanism of Action 14 RandD Progress 14 miltefosine 15 Product Description 15 Mechanism of Action 15 RandD Progress 15 JADO Technologies GmbH - Pipeline Analysis 17 JADO Technologies GmbH - Pipeline Products by Therapeutic Class 17 JADO Technologies GmbH - Recent Pipeline Updates 18 JADO Technologies GmbH - Dormant Projects 19 JADO Technologies GmbH - Locations And Subsidiaries 20 Head Office 20 Appendix 21 Methodology 21 Coverage 21 Secondary Research 21 Primary Research 21 Expert Panel Validation 21 Contact Us 22 Disclaimer 22